PAX2 promotes epithelial ovarian cancer progression involving fatty acid metabolic reprogramming
Cited by 21
Related Papers
CCL18 from tumor‐cells promotes epithelial ovarian cancer metastasis via mTOR signaling pathway
|Molecular Carcinogenesis|2015|69
Metformin reverses stem cell‑like HepG2 sphere formation and resistance to sorafenib by attenuating epithelial‑mesenchymal transformation
|Molecular Medicine Reports|2018|17